HighTower Advisors’s Treace Medical Concepts TMCI Stock Holding History

HighTower Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18K	Sell	13,455 -140	-1%	-$279	﹤0.01%	3765
2025 Q4	$33.3K	Buy	+13,595	New	+$59K	﹤0.01%	3592
2024 Q4	–	Sell	-10,003	Closed	-$58K	–	4047
2024 Q3	$58K	Buy	+10,003	New	+$64.3K	﹤0.01%	3394
2023 Q4	–	Sell	-13,535	Closed	-$174K	–	3852
2023 Q3	$174K	Buy	13,535 +4,943	+58%	+$90.5K	﹤0.01%	2956
2023 Q2	$220K	Buy	8,592 +492	+6%	+$12.7K	﹤0.01%	2798
2023 Q1	$204K	Sell	8,100 -1,900	-19%	-$44.6K	﹤0.01%	2743
2022 Q4	$230K	Hold	10,000	–	–	﹤0.01%	2668
2022 Q3	$221K	Hold	10,000	–	–	﹤0.01%	2540
2022 Q2	$143K	Hold	10,000	–	–	﹤0.01%	2707
2022 Q1	$189K	Hold	10,000	–	–	﹤0.01%	2858
2021 Q4	$186K	Hold	10,000	–	–	﹤0.01%	2800
2021 Q3	$269K	Hold	10,000	–	–	﹤0.01%	2491
2021 Q2	$313K	Buy	+10,000	New	+$318K	﹤0.01%	2349

Other funds holding TMCI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors's TMCI Position: Q1 2026 in Review

HighTower Advisors reduced its Treace Medical Concepts (TMCI) stake by 1% in Q1 2026, selling an estimated $279 and leaving 13,455 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #3765.

HighTower Advisors first reported a position in TMCI in Q2 2021 and has held it in 13 quarters since. The position peaked at $313K in Q2 2021. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

HighTower Advisors held 13,455 shares of Treace Medical Concepts worth $18K as of Q1 2026.
HighTower Advisors sold 140 Treace Medical Concepts shares in Q1 2026, an estimated $279.
Treace Medical Concepts made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3765 holding.
HighTower Advisors first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 13 quarters since.
HighTower Advisors's Treace Medical Concepts position peaked at $313K in Q2 2021.
118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.